Clinical trial Recruiting at 1 site Observational Ages 16 and up

Psychiatric disorders' influence on relapse during complex detox

Official title: Psychiatric Disorders in Addiction - Interest of Screening and Influence on Relapse

Run by University Hospital, Strasbourg, France · NCT07023419 · Data updated 2026-11-12

This project will test whether screening for psychiatric diagnoses can help predict and reduce relapse risk in people aged 16 and older hospitalized for complex detox at CHU de Strasbourg.

Quick facts

Study typeObservational
Ages16 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedDecember 16, 2024
Main results expectedOctober 16, 2026
Study endsOctober 16, 2026
Registry record updatedJune 22, 2025
Trial IDNCT07023419 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People aged 16 or older who were hospitalized in the complex withdrawal unit at the CHU de Strasbourg during the study period and agree to participate.

Probably not a fit

Patients under 16, those not hospitalized in this specific unit or timeframe, or whose relapses are driven primarily by non-psychiatric factors may not gain direct benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study of patients admitted to the complex withdrawal unit at the CHU de Strasbourg between January 1 and November 1, 2024. Investigators will collect psychiatric diagnoses and responses to screening questionnaires and record relapses that occur during hospitalization. They will analyze which psychiatric diagnoses are associated with higher relapse risk and whether routine screening questionnaires improve diagnostic reliability. The findings will be used to suggest ways to adapt care and reduce in-hospital relapse rates.

Why it matters

Potential benefit: If successful, the results could help tailor care to patients' psychiatric risk profiles and reduce in-hospital relapses.

How similar studies have gone: Previous research has linked psychiatric diagnoses to higher relapse risk, but which specific diagnoses matter and the added value of screening questionnaires remain uncertain.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject aged ≥16
* Having been hospitalized in the complex withdrawal unit of the Strasbourg psychiatric clinic during the period from January 1, 2024 to November 1, 2024

Exclusion Criteria:

* Refusal to participate in the study

Where it's running

  • Service d'Addictologie - CHU de Strasbourg - France
    Strasbourg, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.